Naujienos, aktualijos, renginiai
BOSTON–(BUSINESS WIRE)–State Street Corporation (NYSE:STT) today announced that it has appointed Jörg Ambrosius as head of its UK, Europe, Middle East and Africa (EMEA) business. Ambrosius, an 18-year State Street veteran will report to Francisco Aristeguieta, the newly appointed head of State Street’s international business. Ambrosius will succeed Liz Nolan who was named head of … Skaityti toliau
Egon Zehnder makes long-term investment in SQN to bring a proprietary, AI-enabled culture change solution to its clients that allows them to unlock potential. The SQN Living Analytics™ platform, featuring the SQN Flow Operating System™, accurately measures the impact of culture on an organization’s bottom line. It is the first culture change platform and approach … Skaityti toliau
The Lithuanian factoring company previously known as Debifo is re-launching as Factris. The move comes after a merger with the Dutch factoring company, Factris, which was completed in January. Following the merger, the decision was taken to use a single brand name which would be recognised across Europe. “Doing business under the brand name of … Skaityti toliau
Laupheim, Germany and Rankweil, Austria, June 13, 2017 – Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, today announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products … Skaityti toliau
Vilnius, Lithuania, 11 April 2017 – Biotechpharma UAB, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals announced the completion of the expansion of its cGMP facility. The facility expansion contains a separate 2,000 L mammalian production line with a seeding train consisting of 10 L, 50 L and 500 L bioreactors. “Adding an … Skaityti toliau
Laupheim and Munich/Martinsried, Germany, February 2, 2017 – Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler’s biopharmaceuticals business. Rentschler in return will become the first and only contract development and manufacturing organization (CDMO) to … Skaityti toliau
Total client assets on 31 December 2015 reached CHF 224 billion, of which assets under management represented CHF 160 billion Net inflows of funds from private and institutional clients were positive Net profit excluding non-recurring items remained broadly flat vs. 2014. Consolidated net profit amounted to CHF 144 million, up 20% vs. 2014 Fully-loaded Basel … Skaityti toliau